Please login to the form below
chronic pain
This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.
Novartis and Precision BioSciences announce in vivo gene editing collaboration
This can cause problems including delayed growth, organ failure and chronic pain, known as sickle cell crises, and affects 20 million people worldwide.
Latest news
-
Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
Those who do grow up into adulthood will typically experience chronic pain, severe disability and isolation.
-
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
chronic pain, unexpectedly became part of an opioid crisis that has brought grief and loss to far too many families and communities.”. ... In 2019, Purdue filed for bankruptcy following a growing number of lawsuits alleging misleading marketing of
-
FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
Aximris was developed as an abuse and alcohol-deterrent controlled-release oral formulation of oxycodone hydrochloride for pain relief. ... Intellipharmaceutics had been seeking approval for the management of pain severe enough to require daily,
-
Nektar’s opioid analgesic slammed with FDA panel rejection
Panelists unanimously rejected use of the chronic back pain drug. Nektar Therapeutics has been hit with a unanimous FDA panel rejection of its opioid painkiller, over concerns of drug abuse and ... The application for the drug – NKTR-181 – was
-
NICE backs first cannabis-based drugs, both from GW Pharma
There is still no legal route to obtain CBD products to treat chronic pain however, and pressure group End Our Pain tweeted that the guidelines “don’t go far enough to ... didn’t recommend any cannabis-based treatments for pain” associated with
More from news
Approximately 2 fully matching, plus 104 partially matching documents found.
Latest Intelligence
-
Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
From adherence to a healthy lifestyle reducing mortality from type 2 diabetes and cardiovascular disease, to using psychological interventions in managing chronic symptoms, such as pain and fatigue. ... Consequently, symptoms such as fatigue, depression
-
Setting up for success in a post-Brexit, post-pandemic Britain
More than 400, 000 people in the UK live with RA (around 380, 000 in England), and it is recognised as a condition that can cause debilitating physical pain, affect mental ... health and require chronic care.
-
The transatlantic opioid crisis
The benefits of opioids have been known for centuries. The ancient Greeks and Romans were the first to discover their powerful pain-relieving qualities. ... Workers suffering from chronic pain could be treated more quickly and more cheaply through
-
Tools for the digital world
HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.
-
Pursuing better outcomes for people with pain
Using the patient’s voice to change how we conduct R&D. Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits ... for chronic pain conditions.”.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Portland Health adds to staff as business grows
Meanwhile, Russell, who joins Portland Health after more than three years with Insight, is a parliamentary, public affairs and campaigns specialist, with experience in endocrinology, oncology, chronic pain, haematology and sexual
-
Bray Leino opens health and wellbeing PR practice
Diagnostics; and chronic pain for Pfizer.
-
Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer
Pain specialist Zogenix has appointed former Pfizer VP R Scott Shively as its new chief commercial officer. ... for the treatment of chronic pain.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: What's missing in women's health?
phenomenon of HCPs responding poorly to conditions in which women self-report their own pain. ... 30. Lack of regulations lead to many of the devices malfunctioning, leaving women with chronic pain or even sepsis.
-
Spotlight interview: 15 minutes on patient-centricity in pharma
who are going through difficulties with mental health, living with chronic condition, pain management etc. ... We have recently developed an above-brand app called “CML Life” which is for patients with chronic myeloid leukaemia.
-
My MS journey: one patient's search for innovation
Aside from seeing a neurologist, I’ve also been to a chronic pain clinic. ... The doctors gave me injections and showed me different techniques for dealing with the pain.
-
Body image and mental health: The psoriasis connection
1. People with long-term health conditions are at a high risk for body dissatisfaction, particularly when the symptoms physically change the body and are accompanied with chronic pain – which can ... affect the way we experience and perceive our bodies,
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. ... Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients with diabetic neuropathic pain, chronic lower back pain, cancer
More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- A new era for UK-Japanese scientific research relations
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
